Previous studies show lnc MIR4435-2HG may act as an oncogene across several tumor types; specifically, MIR4435−2HG may promote lung cancer by activating TGF-β1 and β-catenin signaling [29–32]. This evidence concerns the gene TGFB1 and neoplasm.